DANBURY, CT--(Marketwired - June 11, 2014) - Biodel Inc. (NASDAQ: BIOD) management will be presenting an overview of the Company's technologies, development programs, and outlook at the JMP Securities Healthcare Conference being held at The Westin New York Grand Central from June 24-25, 2014. Interested parties can access a link to a live webcast of the presentation from the News & Events section of the Biodel website, www.biodel.com. The corporate presentation of the Company will take place on Wednesday, June 25, 2014 at 12:00 p.m. ET.
A live and archived webcast of the presentation will be accessible on the Biodel website at www.biodel.com under "Webcasts" in the "News & Events" section.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. Biodel's product candidates are developed by applying proprietary technologies to existing drugs in order to improve their therapeutic profiles. More information about Biodel is available at www.biodel.com.